Related Experiment Videos
Ovarian tumour antigens as potential targets for immune gene therapy
M Kuiper1, M Peakman, F Farzaneh
1Department of Molecular Medicine, King's College School of Medicine and Dentistry, Denmark Hill, London, UK.
Abstract:
Major new developments in the understanding of the molecular mechanisms involved in immune recognition of self, and immune mediated rejection of foreign antigens, have resulted in the development of a variety of novel therapeutic strategies for the treatment of cancer. Cornerstones of the advances in this area have been the identification of tumour antigens and demonstration of immune recognition of neoplastic cells, most notably in malignant melanoma. There are now a number of clinical immune gene therapy trials in progress for the treatment of cancer by stimulating immune mediated rejection of malignant cells. Here we examine the evidence for immune recognition of ovarian tumour cells and the presence of putative ovarian tumour antigens as potential targets for immune gene therapy of ovarian carcinoma.
Insights
Novel cancer therapies leverage immune recognition of tumor antigens. This study explores immune recognition of ovarian cancer cells and identifies potential targets for immune gene therapy against ovarian carcinoma.
Area of Science:
- Oncology
- Immunology
- Cancer Gene Therapy
Background:
- Advances in understanding immune recognition of self and foreign antigens have spurred novel cancer therapeutics.
- Identification of tumor antigens and immune recognition of neoplastic cells are key to these advances, notably in melanoma.
Purpose of the Study:
- To examine the evidence for immune recognition of ovarian tumor cells.
- To identify potential ovarian tumor antigens as targets for immune gene therapy in ovarian carcinoma.
Main Methods:
- Review of existing literature on immune recognition in cancer.
- Analysis of data regarding ovarian tumor antigens and immune responses.
Main Results:
- Evidence suggests immune recognition of ovarian tumor cells exists.
- Putative ovarian tumor antigens have been identified as potential therapeutic targets.
Conclusions:
- Immune gene therapy holds promise for ovarian carcinoma treatment.
- Targeting identified ovarian tumor antigens could enhance immune-mediated rejection of cancer cells.